The cerebral proteopathies - Neurodegenerative disorders of protein conformation and assembly

被引:75
作者
Walker, LC [1 ]
LeVine, H [1 ]
机构
[1] Pfizer Ann Arbor Labs, Neurosci Therapeut, Ann Arbor, MI 48105 USA
关键词
aging; Alzheimer's disease; amyloid; amyotrophic lateral sclerosis; dementia; diabetes; Huntington's disease; Parkinson's disease; prion proteopathy;
D O I
10.1385/MN:21:1-2:083
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The abnormal assembly and deposition of specific proteins in the brain is the probable cause of most neurodegenerative disease afflicting the elderly These "cerebral proteopathies" include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), prion diseases, and a variety of other disorders. Evidence is accumulating that the anomalous aggregation of the proteins, and not a loss of protein function, is central to the pathogenesis of these diseases. Thus, therapeutic strategies that reduce the production, accumulation, or polymerization of pathogenic proteins might be applicable to a wide range of some of the most devastating diseases of old age.
引用
收藏
页码:83 / 95
页数:13
相关论文
共 91 条
[1]   Prion research: the next frontiers [J].
Aguzzi, A ;
Weissmann, C .
NATURE, 1997, 389 (6653) :795-798
[2]  
[Anonymous], ALZHEIMERS DIS
[3]   INDUCTION OF BETA(A4)-AMYLOID IN PRIMATES BY INJECTION OF ALZHEIMERS-DISEASE BRAIN HOMOGENATE - COMPARISON WITH TRANSMISSION OF SPONGIFORM ENCEPHALOPATHY [J].
BAKER, HF ;
RIDLEY, RM ;
DUCHEN, LW ;
CROW, TJ ;
BRUTON, CJ .
MOLECULAR NEUROBIOLOGY, 1994, 8 (01) :25-39
[4]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[5]   Transgenic mice in the study of polyglutamine repeat expansion diseases [J].
Bates, GP ;
Mangiarini, L ;
Davies, SW .
BRAIN PATHOLOGY, 1998, 8 (04) :699-714
[6]   Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length [J].
Becher, MW ;
Kotzuk, JA ;
Sharp, AH ;
Davies, SW ;
Bates, GP ;
Price, DL ;
Ross, CA .
NEUROBIOLOGY OF DISEASE, 1998, 4 (06) :387-397
[7]   Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene [J].
Botto, M ;
Hawkins, PN ;
Bickerstaff, MCM ;
Herbert, J ;
Bygrave, AE ;
McBride, A ;
Hutchinson, WL ;
Tennent, GA ;
Walport, MJ ;
Pepys, MB .
NATURE MEDICINE, 1997, 3 (08) :855-859
[8]   Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis [J].
Bruening, W ;
Roy, J ;
Giasson, B ;
Figlewicz, DA ;
Mushynski, WE ;
Durham, HD .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :693-699
[9]   Conformational disease [J].
Carrell, RW ;
Lomas, DA .
LANCET, 1997, 350 (9071) :134-138
[10]  
CLARK A, 1991, AMYLOID AND AMYLOIDOSIS 1990, P453